Zeo ScientifiX, Inc.

Zeo ScientifiX, Inc. (ticker: ZEOX) is an OTC-listed biological products, (no diagnostic substances) company. DredgeCap's structured extraction of ZEOX's SEC filings surfaces 20 active risk signals, including 19 late-filing signals, and 1 auditor-change signal. ZEOX reported $1.45M in revenue and -$852K for the period ending 2026-01-31, with operating cash flow of -$471K. Cash and equivalents stood at $1.03M (up 43.1% year-over-year). Total assets of $2.57M are exceeded by total liabilities of $2.95M. Each signal on this page is sourced verbatim from the underlying SEC filing. Use the tabs above to drill into auditor history, going-concern citations, dilution mechanics, cash runway, and the full risk-flag inventory.

ZEOX Cash Runway

Months-of-runway analysis for ZEOX, derived directly from SEC XBRL: latest cash and operating cash flow, monthly burn rate, runway under current conditions. Historical trend + verbatim citation panel ships in Phase 2.

Coming in Phase 2

The dedicated per-ticker cash-runway page will surface a 6-8 quarter trend with the underlying us-gaap:CashAndCashEquivalentsAtCarryingValue + us-gaap:NetCashProvidedByUsedInOperatingActivities citations alongside each data point. In the meantime, see the ranked cross-company view:

All companies ranked by months-of-runway →

Related on ZEOX

Share-count dilution →

Dilution is the natural counterpart to runway burn.

Going-concern history →

Auditor + management language across filings.